Collaboration in Action

Neuroscience at Cambridge is collaborative and dynamic, with members of the community engaged in widespread collaborations across numerous Departments and Institutes. Cambridge Neuroscience also has a formidable track record when it comes to breaking down the barriers between science and business. Large multinational companies such as GlaxoSmithKline, Microsoft and Toshiba have established collaborations with Cambridge collaborations with Cambridge researchers, while numerous spin-off companies are thriving and retaining excellent links with the University.

The addicted brain
Breaking ground in understanding the neurochemical and molecular aspects of addiction

The autistic brain
Pioneering new methods for diagnosing and supporting people with autism and Asperger syndrome

The degenerating brain
Improving diagnosis and treatment for patients with degenerative disorders

The deluded brain
Investigating the biological basis of delusions

The developing brain
Investigating how the normal brain develops to improve treatment for patients with brain injury

The economic brain
Combining biology, medicine, economics, psychology and engineering to increase understanding of basic brain processes

The educated brain
Implementing approaches in neuroscience to improve understanding of learning in children

The genetic brain
Examining the importance of social and environmental influences on brain function and well-being

The inflamed brain
Leading research into novel and effective treatments for multiple sclerosis

The injured brain
Developing new strategies for treating patients with spine injuries

The obese brain
Showing that obesity in humans can be biologically driven and amenable to therapy

The statistical brain
Combining Theoretical Physics and the Life Sciences to uncover how our brains work

Would you like to contribute?

Cambridge Neuroscientists – if you would like your success-story featured, please contact the Cambridge Neuroscience coordinator.